Low T3 is associated with fatigue, weight gain, and reduced exercise tolerance.

Clinical evidence

• Symptom Association: Low triiodothyronine (T3) levels are clinically associated with fatigue and weight gain. In patients experiencing low T3 states—such as hypothyroidism, non-thyroidal illness syndrome (euthyroid sick syndrome), or severe caloric restriction—there is a direct link to systemic fatigue, adaptive downregulation of metabolism, and an increased propensity for weight gain.
• Exercise Tolerance: Reduced levels of active thyroid hormone are strongly associated with decreased physical capacity and exercise tolerance. This is particularly evident in clinical cohorts where low free T3 is a marker of chronic illness or overtraining, correlating with reduced Peak $VO_2$ (oxygen consumption), diminished muscular strength, and early fatigue during aerobic and anaerobic exertion.

Mechanistic explanations

• Mitochondrial Dysfunction: T3 is a primary driver of mitochondrial biogenesis and function. Low T3 levels lead to diminished transcription of key mitochondrial genes, resulting in compromised oxidative phosphorylation, impaired adenosine triphosphate (ATP) production, and reduced overall skeletal muscle mitochondrial activity.
• Metabolic Downregulation: Triiodothyronine directly regulates resting energy expenditure (REE) by modulating uncoupling proteins (such as UCP3 in skeletal muscle) and sodium-potassium ATPase activity. When T3 levels are low, systemic energy expenditure decreases, creating a hypometabolic state that impairs muscle recovery, reduces cellular fuel oxidation, and promotes fat storage.

Clinical implications for 49-year-old female

• Perimenopausal Overlap: For a 49-year-old female, the presentation of low T3, fatigue, and weight gain often overlaps with perimenopausal hormonal transitions, necessitating a comprehensive endocrine evaluation to distinguish thyroid dysfunction from ovarian aging.
• Diagnostic Screening: Given that symptoms like fatigue and weight gain are highly non-specific, clinicians should prioritize free T3, free T4, and sensitive TSH testing alongside markers of metabolic health to guide targeted intervention.

Bottom line

Low T3 is a clinically validated driver of fatigue, weight gain, and reduced exercise tolerance, primarily mediated by a downregulation of resting energy expenditure and impaired skeletal muscle mitochondrial oxidative capacity. Diagnostic evaluation should comprehensively assess both thyroid function and metabolic health to guide precise clinical management.